Progressive VegeGreens Capsules
Natural health product licensed in Canada
- Licence holder
- Jamieson Laboratories Ltd.
- NPN or DIN-HM
- 80034797
- Status
- Inactive licence
- Licence date
- 20 August 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vaccinium macrocarpon Source : Fruit | 6.25 mg | Not calculated |
| Crataegus laevigata Source : Fruit | 1.25 mg | Not calculated |
| Momordica charantia Source : Fruit(s) | 3.33 mg | Not calculated |
| Linum usitatissimum Source : Graine(s) | 8.34 mg | Not calculated |
| Ascophyllum nodosum Source : Plante(s) entière | 1.67 mg | Not calculated |
| Avena sativa Source : Enveloppe | 2.5 mg | Not calculated |
| Triticum aestivum Source : Plante(s) entière | 8.33 mg | Not calculated |
| Fagopyrum esculentum Source : Plante(s) entière | 6.25 mg | Not calculated |
| (3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol Source : Tagetes erecta - Fleur | 0.17 mg | Not calculated |
| Brassica oleracea var. botrytis Source : Fleur | 5 mg | Not calculated |
| 1-[(2E, 4E)-5-(1,3-Benzodioxole-5-yl)-1-oxo-2,4-pentadiényl] pipéridine Source : Piper nigrum - fruit | 0.08 mg | Not calculated |
| Brassica oleracea var. viridis Source : Plante(s) entière | 2.92 mg | Not calculated |
| Astragalus membranaceus Source : Racine | 2.5 mg | Not calculated |
| Malus pumila Source : Fruit(s) | 8.75 mg | Not calculated |
| Brassica oleracea var. italica Source : Fleur | 8.33 mg | Not calculated |
| Hordeum vulgare Source : Plante(s) entière | 62.5 mg | Not calculated |
| Carthamus tinctorius Source : Graine(s) | 0.84 mg | Not calculated |
| Ananas comosus var. comosus Source : Fruit | 1.67 mg | Not calculated |
| Chionanthus virginicus Source : Écorce de racine | 2.5 mg | Not calculated |
| Apium graveolens var. dulce Source : Graine(s) | 1.67 mg | Not calculated |
| Vaccinium myrtillus Source : Fruit Extraction ratio : 4:1 Dry plant equivalent : 3.32 mg | 0.83 mg | Not calculated |
| psi,psi-carotène Source : Solanum lycopersicum - fruit | 0.25 mg | Not calculated |
| Cucurbita pepo Source : Graine(s) | 1.46 mg | Not calculated |
Non-medicinal ingredients
Eau purifiée, Maltodextrine, Hypromellose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 6 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A source of antioxidants for the maintenance of good health. Helps to support liver function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80034797
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Vaccinium macrocarpon
Read the warning, when it applies and the studies cited
CRANBERRY - VACCINIUM MACROCARPON
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of kidney stones (Gettman et al. 2005; Terris et al. 2001).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Aston et al. 2006; Rindone and Murphy 2005; Grant 2004).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: (Recurrent) urinary tract infection.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 27 March 2026
DRIED CRANBERRY JUICE
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of kidney stones (Gettman et al. 2005; Terris et al. 2001).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Aston et al. 2006; Rindone and Murphy 2005; Grant 2004).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: (Recurrent) urinary tract infection.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
- Crataegus laevigata
Read the warning, when it applies and the studies cited
Hawthorn
Route of administration: Oral (ESCOP 2009; Bradley 2006; Mills and Bone 2000)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking cardiac glycosides (e.g., digoxin) or blood pressure or heart medications (Brinker 2010; Bradley 2006).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have chest pain, irregular heartbeat, or shortness of breath.
- Linum usitatissimum
Read the warning, when it applies and the studies cited
FLAXSEED - LINUM USITATISSIMUM
Route of administration: Oral
Cautions and warnings
Applies to products providing 5 g or more of flaxseed per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (EMA 2015).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (EMA 2015; ESCOP 2003).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Laxative; Promotion of bowel movement; Constipation.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Applies to products providing 5 g or more of flaxseed per day.
Do not use if you have difficulty swallowing (EMA 2015; ESCOP 2003).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2015; Gardner and McGuffin 2013; Brinker 2010; ESCOP 2003).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: All products.
Stop use if hypersensitivity/allergy occurs (EMA 2015; León et al. 2003).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Astragalus membranaceus
Read the warning, when it applies and the studies cited
ASTRAGALUS - ASTRAGALUS MEMBRANACEUS
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an autoimmune disorder (Brinker 2010; Upton 1999).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Condition of application: Traditional Chinese Medicine.
Do not use if you have exterior excess, stagnation, yin deficiency or excess heat (Bensky et al. 2004; Chen and Chen 2004).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Vaccinium myrtillus
Read the warning, when it applies and the studies cited
BILBERRY - VACCINIUM MYRTILLUS - Buccal
Route of administration: Buccal (Blumenthal et al. 2000)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 30 January 2026
BILBERRY - VACCINIUM MYRTILLUS - Oral
Route of administration: Oral (Blumenthal et al. 2000)
Cautions and warnings
Condition of application: Relief of diarrhea.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.